Skip to main content
SHIELD THERAPEUTICS PLC logo

SHIELD THERAPEUTICS PLC — Investor Relations & Filings

Ticker · STX ISIN · GB00BYV81293 LEI · 213800G74QWY15FC3W71 IL Manufacturing
Open in API
Filings indexed 408 across all filing types
Latest filing 2023-01-09 Regulatory Filings
Country GB United Kingdom
Listing IL STX

About SHIELD THERAPEUTICS PLC

https://www.shieldtherapeutics.com/

Shield Therapeutics is a commercial-stage specialty pharmaceutical company focused on addressing iron deficiency. The company's mission is to improve the lives of patients suffering from this condition, with or without anemia. Its lead product is Accrufer® (ferric maltol), also marketed as Feraccru®, a novel, stable, non-salt-based oral therapy. This innovative pharmaceutical is broadly indicated for use in adults across multiple therapeutic categories, aiming to provide an effective and well-tolerated treatment for a significant unmet medical need.

Recent filings

Filing Released Lang Actions
Partial AOP Loan Conversion
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details a specific corporate action: the conversion of a shareholder loan into ordinary shares, which results in a change in the company's issued share capital and subsequent application for admission to trading. This type of announcement, which is a formal regulatory disclosure disseminated via the RNS system, fits best under the general 'Regulatory Filings' category (RNS), as it is not a full financial report (10-K, IR), an earnings release (ER), a management discussion (MDA), or a specific transaction report like Director's Dealing (DIRS) or a formal Share Issue (SHA), although it does involve shares. Given the context of a standard, non-specific regulatory news service announcement, RNS is the most appropriate classification.
2023-01-09 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly labeled with 'RNS Number' and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership (crossing thresholds) by an individual or entity, which directly corresponds to the definition of Major Shareholding Notification. The content details the shareholder (Premier Miton Group plc), the date the threshold was crossed (06-Jan-2023), and the resulting percentage of voting rights (5.412900%). This fits the 'Major Shareholding Notification' category (MRQ) better than the general 'Regulatory Filings' (RNS), as MRQ is a specific type of regulatory disclosure.
2023-01-09 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with 'RNS Number' and contains the standard header/footer information associated with Regulatory News Service (RNS) announcements from the London Stock Exchange. The content details a 'TR-1: Standard form for notification of major holdings' filed by Jupiter Fund Management PLC regarding an acquisition of voting rights in Shield Therapeutics PLC, crossing a threshold (from 4.68% to 6.70%). This type of filing, which reports changes in significant share ownership, directly corresponds to the Major Shareholding Notification category (MRQ). Although RNS is a general service, MRQ is the specific classification for this content type.
2023-01-09 English
Result of General Meeting & Open Offer
AGM Information Classification · 99% confidence The document is an RNS announcement from Shield Therapeutics PLC, dated January 5, 2023. The primary content details the 'Result of General Meeting & Open Offer,' including the voting results for resolutions and the outcome of the Open Offer fundraising. Crucially, it contains a section titled 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them,' which details a purchase of shares by Director Dr. Christian Schweiger. This specific disclosure of insider transactions (director's dealing) related to a capital event strongly points towards the 'Director's Dealing' classification (DIRS). While it also reports on voting results (DVA) and capital raising (CAP), the detailed disclosure of a director's personal transaction using the standard regulatory format makes DIRS the most specific and accurate classification for this particular filing's core regulatory requirement being met.
2023-01-05 English
PDMR Transaction Notification
Director's Dealing Classification · 100% confidence The document is identified by the 'RNS Number' header and contains a 'PDMR Transaction Notification' regarding the disposal of Ordinary Shares by the Chief Executive Officer (Gregory Madison) to cover exercise costs and tax liabilities. This type of filing, detailing personal share transactions by company directors and executives, directly corresponds to the definition of Director's Dealing (DIRS). Although it is distributed via RNS, the specific content mandates the DIRS classification over the general RNS fallback.
2022-12-28 English
Total Voting Rights Update
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number : 9635K' and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange.' The content details the 'Total Voting Rights Update' as required by the FCA's Disclosure and Transparency Rule 5.6.1, providing the total number of issued shares (259,387,708). This type of mandatory, periodic disclosure regarding share capital and voting rights, distributed via the official regulatory news service (RNS), fits best under the general 'Regulatory Filings' category, as there is no specific code for 'Total Voting Rights Update' and it is not a major shareholding change (MRQ) or a director's dealing (DIRS). Given the source and nature, RNS is the most appropriate classification.
2022-12-28 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.